- Home
- DXLG vs PLUR Comparison
DXLG vs PLUR Comparison
Compare DXLG & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- PLUR
- Stock Information
- Founded
- DXLG 1976
- PLUR 2001
- Country
- DXLG United States
- PLUR Israel
- Employees
- DXLG N/A
- PLUR N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DXLG Consumer Discretionary
- PLUR Health Care
- Exchange
- DXLG Nasdaq
- PLUR Nasdaq
- Market Cap
- DXLG 55.4M
- PLUR 44.7M
- IPO Year
- DXLG 1987
- PLUR N/A
- Fundamental
- Price
- DXLG $1.41
- PLUR $4.70
- Analyst Decision
- DXLG Strong Buy
- PLUR Strong Buy
- Analyst Count
- DXLG 1
- PLUR 1
- Target Price
- DXLG $2.50
- PLUR $12.00
- AVG Volume (30 Days)
- DXLG 216.3K
- PLUR 11.7K
- Earning Date
- DXLG 08-27-2025
- PLUR 11-11-2025
- Dividend Yield
- DXLG N/A
- PLUR N/A
- EPS Growth
- DXLG N/A
- PLUR N/A
- EPS
- DXLG N/A
- PLUR N/A
- Revenue
- DXLG $447,744,000.00
- PLUR $1,034,000.00
- Revenue This Year
- DXLG N/A
- PLUR $395.40
- Revenue Next Year
- DXLG $3.56
- PLUR $186.32
- P/E Ratio
- DXLG N/A
- PLUR N/A
- Revenue Growth
- DXLG N/A
- PLUR 203.23
- 52 Week Low
- DXLG $0.90
- PLUR $3.33
- 52 Week High
- DXLG $3.10
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- DXLG 56.66
- PLUR 45.12
- Support Level
- DXLG $1.20
- PLUR $4.33
- Resistance Level
- DXLG $1.52
- PLUR $4.96
- Average True Range (ATR)
- DXLG 0.08
- PLUR 0.27
- MACD
- DXLG 0.01
- PLUR -0.02
- Stochastic Oscillator
- DXLG 65.62
- PLUR 38.14
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.